Hydromorphone Hydrochloride 00409-3365
Product NDC
00409-3365- Manufacturer
- Hospira, Inc.
- Dosage Form
- Injection, Solution
- Route
- Intramuscular, Intravenous, And Subcutaneous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- December 1, 2011
- Listing Expires
- December 31, 2026
- Application
- NDA200403
Active Ingredients
| Ingredient | Strength |
|---|---|
| Hydromorphone Hydrochloride | 2 mg/mL |
Drug Class
Full Opioid Agonists [MoA]Opioid Agonist [EPC]
Packaging Options(1)
10 VIAL, SINGLE-DOSE in 1 CARTON (0409-3365-10) / 1 mL in 1 VIAL, SINGLE-DOSE (0409-3365-11)